Assignee
INTEROLIGO CORP
KR·3 granted patents·8 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
11 records- 0161US2024327848A1Non-natural nucleic acid ligand, uses thereof, and pharmaceutical composition for preventing or treating cancer comprising same as active ingredientINTEROLIGO CORP·Filed 2022·Application pending·0 cites
- 0261US2024336926A1Pharmaceutical composition for treating triple negative breast cancer, containing non-natural nucleic acid ligand as active ingredientINTEROLIGO CORP·Filed 2022·Application pending·0 cites
- 0361US2025367301A1Pharmaceutical composition for preventing or treating triple-negative breast cancer, comprising oligonucleotide as active ingredientINTEROLIGO CORP·Filed 2022·Application pending·0 cites
- 0457US2025049927A1Modified oligonucleotide-drug conjugate and use thereofINTEROLIGO CORP·Filed 2022·Application pending·0 cites
- 0552US12448624B2Modified nucleic acid having improved treatment efficacy, and anticancer pharmaceutical composition containing sameINTEROLIGO CORP·Filed 2019·Granted Oct 21, 2025·0 cites·11 claims
- 0652US2023055235A1Anti-cancer immunotherapeutic composition for treating cancerINTEROLIGO CORP·Filed 2020·Application pending·0 cites
- 0751US11499156B2Biomolecule imaging method using aptamerINTEROLIGO CORP·Filed 2018·Granted Nov 15, 2022·0 cites·12 claims
- 0844US2019338284A1Complex for drug delivery and stabilization and preparation method thereofINTEROLIGO CORP·Filed 2017·Application pending·0 cites
- 0944US2023242618A1Atelocollagen and use thereofINTEROLIGO CORP·Filed 2021·Application pending·0 cites
- 1044US2023220399A1Novel nucleic acid ligand and method for identifying sameINTEROLIGO CORP·Filed 2021·Application pending·0 cites
- 1141US11458120B2Aptamer-drug conjugate and use thereofINTEROLIGO CORP·Filed 2017·Granted Oct 4, 2022·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →